← FDA DRUG APPROVALS

FDA ANDA · ANDA088367

LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER

Sponsor: HOSPIRA

APPLICATION
ANDA088367
TYPE
ANDA
ORIGINAL APPROVAL
1984-07-31
LATEST ACTION
2002-01-02
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINERDiscontinued
LIDOCAINE HYDROCHLORIDE 10% · INJECTABLE · INJECTION

Approval history

2002-01-02Labeling · Supplement 11AP
1996-10-03Manufacturing (CMC) · Supplement 9AP
1991-07-23Labeling · Supplement 7AP
1990-04-18Labeling · Supplement 5AP
1987-10-14Manufacturing (CMC) · Supplement 4AP
1986-08-01Manufacturing (CMC) · Supplement 3AP
1986-08-01Manufacturing (CMC) · Supplement 2AP
1985-04-12Manufacturing (CMC) · Supplement 1AP
1984-07-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →